Natus Medical reported $12.92M in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abiomed ABMD:US $ 74.76M 16.89M
Accuray ARAY:US $ -0.64M 1.3M
Atricure ATRC:US $ -15.13M 1.44M
Boston Scientific BSX:US $ 671M 33M
Cardiovascular Systems CSII:US $ -9.6M 0.69M
Edwards Lifesciences EW:US $ 440.8M 73.9M
Inogen INGN:US $ -13.99M 7.1M
Insulet PODD:US $ 29.3M 4.1M
Masimo MASI:US $ 70.01M 14.29M
Medtronic MDT:US $ 2345M 233M
Thermo Fisher Scientific TMO:US $ 3355M 760M